Technology Management

Two implantable cardioverter defibrillator (ICD) systems made by Biotronik were approved by the U.S. Food and Drug Administration, the company announced July 19.
For stroke survivors, recovering physical abilities often involves relearning how to walk. To help, researchers at Boston University’s College of Health and Rehabilitation Sciences have developed an “exosuit” to support a patient’s movements.
Biotechnology company Amgen has received priority review from the U.S. Food and Drug Administration (FDA) for its PCSK9 inhibitor, Repatha.
Penumbra Inc. is recalling its Penumbra 3D Revascularization device due to a risk of delivery wire breakage or separation during use, according to a July 21 U.S. Food and Drug Administration (FDA) release.
Healthcare is just beginning to realize the potential of virtual reality, but for two conjoined sisters in Minnesota, the technology couldn't have done more. Paisleigh and Paislyn Martinez survived a highly risky nine-hour surgery to separate the two who were attached in the chest and torso areas.
Mountain View, California-based AliveCor, which makes the personal electrocardiogram, Kardia Mobile, has plans to enhance the device with a new detection feature through a collaboration with Mayo Clinic.
Because liver transplants are among the surgeries at the highest risk to cause cardiac problems, researchers at Northwestern Medicine in Chicago have developed an app that can predict a liver transplant patient’s one-year risk of dying or being hospitalized due to a heart attack or other cardiac event.
New research at the University of Cincinnati will test a non-invasive brain technology to treat stroke patients, reports USA Today's Cincinnati affiliate.
According to a new study, pacemakers and other cardiac devices could help solve forensic cases by revealing a person’s time and cause of death where an autopsy can’t.
St. Louis-based Stereotaxis, a cardiac technology maker, launched its e-Contact module in Europe last week, bringing a device to market that can significantly ease the jobs of cardiologists.
Eko Devices, a tech company in Berkeley, California, has received U.S. Food and Drug Administration (FDA) approval for its combined digital stethoscope and electrocardiogram that can be used from home, reports Qmed.
The U.S. Food and Drug Administration (FDA) has announced a Class 1 recall of the HeartMate II LVAS Pocket System Controller from Abbott-Thoratec.
Northwell Health, the largest healthcare provider in New York, has partnered with Peerbridge Health to help further develop a new remote electrocardiogram as the company seeks approval from the U.S. Food and Drug Administration (FDA).
Dublin-based Medtronic revealed encouraging results from a study completed on its Micra Transcatheter Pacing System (TPS), which showed a 99.6 percent implant success rate and low chances of major complications occurring.
Abbott announced its smartphone-compatible insertable cardiac monitor (ICM) has gained CE Mark. The device allows physicians to remotely monitor patients, potentially diagnosing arrhythmias and atrial fibrillation (AFib).
May 11, 2017 | Technology Management
Just last week, Lake Oswego, Oregon-based Biotronik announced that two of its new products, the SentusProMRI and its MultiPole Pacing technology, were approved by the U.S. Food and Drug Administration (FDA). This week at the annual Heart Rhythm Society conference in Chicago, the company showed off the new devices.
Technology Management
May 09, 2017 | Technology Management
Abiomed has debuted the third generation of its Impella CP heart pump, a device designed to unload the heart and let it naturally recover. 
Technology Management
May 08, 2017 | Technology Management
Biotronik’s Sentus ProMRI, a thin quadripolar left ventricular lead, has been approved by the U.S. Food and Drug Administration (FDA), the company announced today.
Technology Management
Apr 19, 2017 | Technology Management
In an effort to reduce and prevent the incidence of heart disease, researchers in Europe have developed a new tool that designs personalized workouts for patients at risk or living with the condition.
Technology Management
Apr 19, 2017 | Technology Management
Biomedical technology company Biotronik has launched the smallest MR-conditional tachycardia lead available in the U.S.
Technology Management
Mar 27, 2017 | Technology Management
Germany-based Biotronik has launched its smallest and lightest set of heart pacemakers, branded the Edora series, which specialize in patient safety, therapy and comfort while being MR-conditional.
Technology Management